The effects of human recombinant megakaryocyte growth and ation of the receptor itself and of a number of transducing development factor (MGDF) (also known as thrombopoietin molecules. 27 The activation of several tyrosine kinases as well vators, transcription (STATs) has recently been found to be However, the greatest response (proliferation index Ͼ7) was regulated by a number of hemopoietic cytokine receptors. 
Introduction known of its effect on the clonal growth of leukemic progenitors and on the functional activation of c-mpl on AML blasts. Proliferation and maturation of hematopoietic cells are strictly
The aim of our study was to evaluate the effects of a truncregulated by factors that positively or negatively modulate ated recombinant human c-mpl ligand, megakaryocyte primitive stem cell proliferation and multilineage or unilinegrowth and development factor (MGDF) on the proliferation age differentiation. These effects are mediated through the and clonal growth of leukemic progenitors from AML patients binding of extracellular factors to specific cell surface recepand to investigate the ability of MGDF to induce tyrosine tors. Human leukemic cells have been shown to express funcphosphorylation in responsive and unresponsive AML cases. tional receptors for a variety of hematopoietic growth factors Our data demonstrate that MGDF is a stimulator not only (HGF), including granulocyte colony-stimulating factor (Gfor the proliferation, but also for the clonal growth of leukemic CSF), GM-CSF, IL-3, KL and FL. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Above all, leukemic cells myeloid cells in a consistent proportion of AML patients. have been shown to respond with proliferation to the presence Moreover, biochemical studies on MGDF-mediated AML proof these factors in vitro and in some instances also in vivo. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] liferation, demonstrate that MGDF induces tyrosine phos-A novel protein, the c-mpl ligand (TPO), has been recently phorylation of a 90 kDa protein(s) in MGDF responsive cells identified and cloned. [19] [20] [21] [22] [23] [24] This cytokine binds to the c-mpl but not in unresponsive ones. In addition, in one responsive receptor and stimulates megakaryocyte proliferation and case co-immunoprecipitation studies demonstrate that the maturation in vitro and in vivo. [25] [26] [27] [28] [29] [30] c-mpl is the human hom-90 kDa band included both STAT5a and c-Mpl. ologue of the viral oncogene v-mpl, naturally transduced in the genome of the highly leukemogenic murine retrovirus, the myeloproliferative leukemia virus (MPLV). 31 c-mpl is a memMaterials and methods ber of the cytokine receptor superfamily, which also includes the receptors for IL-3, G-CSF, GM-CSF and erythropoietin 532 tory anemia with excess blasts (RAEB). Leukemia samples
Clonogenic assay (CFU-L)
were classified according to the French-American-British (FAB) classification, based on morphological and cytochem-AML blast cells isolated from peripheral blood were seeded in a density of 5 × 10 3 to 1 × 10 5 cells/ml in a 1 ml mixture ical criteria, and confirmed on phenotypic analysis. After thawing the viability of cells was Ͼ90%. Blasts (Ͼ95% of containing either serum-free IMDM or 10% fetal bovine serum (FBS) and 3% agar. Recombinant cytokines were added at the leukocytes) were isolated by gradient centrifugation with Lymphoprep (density 1077; Nyegaard, Oslo, Norway) and following concentrations: IL-3 20 ng/ml, KL 50 ng/ml, GM-CSF 20 ng/ml, EPO 3 U/ml. All the dishes were set up in the depleted from adherent cells by plastic adherence for 90 min at 37°C (non-adherent low density cells, NALD).
absence or in the presence of 50 ng/ml MGDF. Control dishes contained medium alone and a combination of G-CSF, GMPeripheral blood was used to minimize the possibility of contamination of colony forming units-leukemia (CFU-L) with CSF, IL-3 and KL. After 10 days of incubation all the aggregates containing more than eight cells were enumerated in normal colony-forming units granulocyte-macrophage (CFU-GM), because of the very low number of CFU-GM present in triplicate dishes and the results averaged. Morphological examination of the colonies was performed normal blood.
by the whole-dish triple staining technique of Phillips et al 50 and by the Giemsa staining. The cells within the colonies were similar in morphology to the patient's leukemic blast cells.
Recombinant human cytokines
Recombinant human (rh) kit-ligand (KL), rh interleukin 3 (IL-
Western blot analysis and immunoprecipitation 3) , rh granulocyte colony-stimulating factor (G-CSF), rh grastudies nulocyte-macrophage colony-stimulating factor (GM-CSF) were from Genzyme (Cambridge, MA, USA); rh erythropoietin AML or M07e cells (20 × 10 6 ) were resuspended in serum-free (EPO, Eprex) was from Cilag (Milan, Italy), recombinant 1640 RPMI medium and incubated at 37°C overnight, then human FLT3-ligand (FL) was prepared at Immunex (Seattle, untreated and MGDF-treated (10 min with 20 ng/ml), WA, USA). Recombinant human megakaryocyte growth extracted with cold detergent insoluble matrix (DIM) buffer development factor (MGDF) (gift of Amgen, Thousand Oaks, (50 mm Pipes pH 6.8, 100 mm NaCl, 5 mm MgCl 2 , 300 mm CA, USA) was expressed in E. coli using a plasmid expressing sucrose, 5 mm EGTA, 2 mm sodium orthovanadate) plus 1% the erythropoietin-like domain of mpl ligand.
Triton X-100 and a cocktail of protease inhibitors (1 mm phenylmethylsulfonylfluoride (PMSF), 10 g/ml leupeptin, 0.15 U/ml aprotinin, 1 g/ml pepstatin A) for 20 min at 4°C, and centrifuged at 15 000 g for 20 min. The clarified super-3 H-thymidine incorporation assay natant was precleaned for 1 h with 50 l of Sepharose protein A (3 mg/sample). The precleaned cell lysates were then adsorbed by antiserum coupled to Sepharose-protein A. The mitogenic activity of MGDF alone or in combination with other colony-stimulating factors (CSF) (GM-CSF, IL-3, KL, EPO Bound proteins were washed several times in DIM buffer and eluted in boiling Laemmli buffer. Eluted proteins were suband FL) was determined in a 3 H-thymidine incorporation assay. Leukemia cells were plated at a concentration of jected to 8% SDS-PAGE. Proteins were then transferred electrophoretically to nitrocellulose; the filters were incubated 5 × 10 4 to 1 × 10 5 cells/well in 96-well flat bottom microtiter plates (200 l/well) containing Iscove's modified Dulbecco's with blocking solution (10% low fat milk in 20 mm Tris-HCl pH 7.6 and 17 mm NaCl) for 1 h. Antiserum was then added medium (IMDM) in serum-free medium and 50 ng/ml of recombinant human MGDF alone or in combination with at the same solution, and the incubation was carried out for 2 h at room temperature. For detection, the filters were other CSF. The other factors were used at the following concentration: GM-CSF 20 ng/ml, KL 50 ng/ml, EPO 3 U/ml, FL washed three times (10 min each wash) with PBS, 0.05% Tween 20 and reacted for 1 h at room temperature with 100 ng/ml. The concentrations were those which in previous experiments sustained optimum leukemic growth. Control horseradish peroxidase-conjugated protein A. The enzyme was removed by washing as above. The filters were reacted cultures contained medium alone, or a combination of GM-CSF, IL-3 and KL. Serum-free medium was constituted by for 1 min with a chemiluminescence reagent (ECL) and exposed to an autoradiography film for 1-15 min. IMDM containing sodium selenite 0.0114 ng/ml, ␤-mercaptoethanol 0.75 m, antibiotics, deionized bovine serum albumin (BSA; 20 mm), BSA-adsorbed cholesterol (4 g/ml), soybean lecithin (12 g/ml), iron-saturated human transferrin (50 m), Antisera insulin (1.7 × 10 mm), and l-glutamine (2 mm). All chemicals were from Sigma (Aldrich srl, Gallarete Mi, Italy).
Anti-phosphotyrosine monoclonal antibody was from UBI (Upstate Technology, Lake Pacific, NY, USA). After a culture period of 72 h at 37°C and 5% CO 2 , the cells were exposed to a 8-h pulse of 2 Ci 3 H-thymidine Affinity-purified polyclonal anti-c-Mpl antibody was prepared from serum of a rabbit immunized against a GST-fusion (5 Ci/mmol; Amersham, Buckingham, UK). Finally, the cells were harvested on glass fiber strips and incorporated radioprotein, containing the aminoacid sequence corresponding to residues 519-568 (GenBank IM, accession number M90102), activity (counts per minute, c.p.m.) measured in a scintillation counter (Packard, Downers Grove, IL, USA). All assays were as previously described. 51 The cDNA encoding the GSTfusion protein with the intracytoplasmic portion of the c-Mpl performed in triplicate. Proliferation index (PI) was calculated by dividing the number of c.p.m. of growth factor containing was generated by ligating the PCR fragment, that introduces a novel restriction endonuclease site EcoRI of the c-mpl, into wells by the number of c.p.m. of medium alone containing wells. 13 the EcoRI site of pGEX-5X vector (Pharmacia Biotech, Ala-meda CA, USA). The GST-fusion protein was expressed in growth factors, such as GM-CSF, IL-3, KL and FL, known to promote AML growth (Table 1) . GM-CSF, IL-3, KL and FL Escherichia coli, and protein was purified as described. 52 
Effect of MGDF on colony growth of clonogenic leukemic precursors (CFU-L)

Results
The number of colonies that grew in the absence of exogenously added growth factors ('autonomous growth') or in the Effect of MGDF on leukemic cell proliferation presence of a combination of G-CSF, GM-CSF, IL-3 and KL is presented in Table 2 . The effect of MGDF on the growth of The effect of MGDF on the proliferation of primary leukemic blast cells was assessed in 24 AML cases (Table 1) . A significlonogenic leukemic progenitors was assessed in 15 cases capable of clonal growth. In preliminary experiments leucant proliferative response (proliferation index above 1.5) was detected in nine of 23 fresh leukemias tested; the responding kemic colony growth was stimulated in a dose-dependent way by increasing concentrations of MGDF; significant increase in cells belonged to all FAB subtypes. However, the highest proliferation index (greater than 7) of MGDF-stimulated blasts, colony number was reached at 0.1 ng/ml and maximum stimulation was observed at 10 to 100 ng/ml (not shown). was found in M6 and M7 subtypes (AML21 and 24). In AML21 (M6) a strong proliferative response was also elicited by GMTherefore in the subsequent experiments a concentration of 50 ng/ml was used. MGDF significantly stimulated the growth CSF, IL-3 and KL. Blast cells from AML24 (M7) proliferated well only in response to MGDF and KL; their association of leukemic colonies either by itself, or when combined with other hemopoietic growth factors. was synergistic.
The same cells were also cultured with other hemopoietic The average results, expressed as mean percent growth, are Leukemia cells (NALD peripheral blood cells) were plated at concentrations of 5 × 10 4 to 1 × 10 5 cells/well in triplicate 96-well flat bottom microtiter plates containing 200 l serum-free medium. Dishes contained medium alone, MGDF alone or the indicated growth factors with (+) or without (−) MGDF. MGDF was used at 50 ng/ml; GM-CSF at 20 ng/ml, IL-3 at 20 ng/ml, EPO at 3 U/ml, FL at 100 ng/ml. Proliferation index was calculated by dividing the c.p.m. of the growth factor-containing wells by the c.p.m. of the medium-alone containing wells. A significant response (defined as proliferation index Ͼ1.5) is highlighted by bold printing; an additive effect of MGDF is underlined. ND, not done; f, fresh cells; c, cryopreserved cells.
Figure 1
Influence of MGDF on myeloid leukemia clonogenic progenitor growth from AML. Average results from 14 different AML samples. Results are expressed as mean ± s.e.m. of the percent growth in the presence of optimal MGDF concentrations (50 ng/ml) compared with control dishes (containing medium alone or hemopoietic growth factors in the absence of MGDF). The number of cases evaluated is in brackets. ‫ء‬P Ͻ 0.05; ‫‪P‬ءء‬ Ͻ 0.01. 
852 ± 16 347 ± 11 22 M6 6 ± 0.5 86 ± 2 3 9 ± 2 23 M7 166 ± 4 586 ± 14 230 ± 7 24 M7 4 ± 0 252 ± 10 59 ± 2 NALD peripheral blood blasts 2.5 × 10 4 to 1 × 10 5 were seeded in triplicate agar dishes containing medium alone or a combination of growth factors. a GM-CSF 20 ng/ml, IL-3 10 ng/ml, G-CSF 20 ng/ml and KL 50 ng/ml. MGDF was used at 50 ng/ml. Aggregates containing more than eight cells were counted after 10 days of incubation. Results are expressed as mean aggregate number ± s.d. ND, not done.
Figure 2
Number of leukemic colonies (from AML21, 9, 23, 16, 22) generated by 5 × 10 4 NALD leukemic blasts cultured for 10 days in the presence of control medium, MGDF or other hematopoietic growth factors. Mean ± s.d. of triplicate dishes.
represented in Figure 1 . Leukemic myeloid clonogenic cells Protein tyrosine phosphorylation induced by MGDF in AMLs from four AML samples did not grow in the absence of exogenously added growth factors (the individual growth of these samples is represented in Table 3 ). In three of these cases the addition of plateau concentrations of MGDF as a Hematopoietin receptors, such as c-mpl, lack an intrinsic tyrosine kinase domain; ligand binding characteristically induces single factor sustained the growth of a few colonies (Table 3) . A variable number of colonies grew in the presence of optimal tyrosine phosphorylation of multiple intracellular proteins, a requisite event for the initiation of signal transduction. The concentrations of GM-CSF, IL-3 or KL. In three cases the addition of plateau concentrations of MGDF increased (up to finding that MGDF is able to stimulate both AML blast pro- In order to characterize the tyrosine phosphorylated p90 observed in MGDF responsive cases, we performed coimmuand 3).
In an attempt to reduce the influence of endogenously pronoprecipitation experiments on unstimulated and MGDFstimulated blast cells from case No. 2. Cell lysates were duced growth factors on the MGDF-stimulated growth of leukemic clonogenic cells, experiments were set up in serumimmunoprecipitated with the anti-c-Mpl antiserum and immunoblotted with the anti-phosphotyrosine antibody. The results free conditions and with decreasing concentrations of seeded leukemic blasts. As depicted in Table 4 the frequency of GMdepicted in Figure 5a demonstrate the presence of two tyrosine phosphorylated bands of about 87 and 95 kDa. Given CSF-and IL-3-dependent clonogenic progenitors did not change significantly when increasing concentrations of leuthat one of the STAT proteins, namely STAT5a is a 94 kDa protein that becomes tyrosine phosphorylated upon MGDF kemic blasts were seeded. By contrast, the frequency of KL-, FL-and MGDF-dependent leukemic clonogenic progenitors stimulation, 39 we tried to assess whether the anti-c-Mpl coprecipitating 95 kDa phosphoprotein was indeed the STAT5a. considerably changed when increasing concentrations of leukemic blast cells were cultured. MGDF did not show any syn-
The same filter was washed and reblotted with an anti-STAT5a antiserum. The results reported in Figure 5b demonstrate that, ergistic effect with IL-3 and was only moderately synergic with GM-CSF stimulated leukemic clonogenic growth at all blast in these cells, c-Mpl physically associates with STAT5a only upon MGDF stimulation and that at least one of the 95 kDa concentrations. Conversely, a strong synergistic effect of MGDF with KL-and FL-dependent leukemic growth was phosphoproteins observed in the anti-c-Mpl immunoprecipitate from MGDF-stimulated cells is STAT5a. Moreover, since detected even at low cell concentrations of blast cells cultured.
c-Mpl is a 87 kDa protein and it comigrates with the 87 kDa phosphoprotein, it is likely that this tyrosine phosphorylated such as GM-CSF and G-CSF have been studied safely in clinical trials in patients with AML, with no evidence of overall protein is indeed the phosphorylated MGDF receptor.
worsening of leukemia outcome.
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In normal hematopoiesis MGDF acts as a growth factor for megakaryocytopoiesis. [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] In addition, recent reports demonDiscussion strate that c-mpl ligand can also enhance the proliferation of early erythroid progenitors. 53, 54 Indeed, c-mpl is a member of Although leukemic progenitor cells apparently have escaped normal regulation by stimulatory or inhibitory factors in vivo, the cytokine receptor superfamily, with extensive aminoacid homologies to the receptors for erythropoietin, GM-CSF and clonogenic leukemic precursor cell growth in vitro of primary leukemias has been shown to be dependent on hematopoietic IL-3. [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Moreover, it has been demonstrated that human CD34 + CD38 − cells express c-mpl. The expression of c-mpl factors in most cases. Several factors that exhibit stimulatory activity for normal hematopoietic progenitor cells also stimuby early progenitors raises the possibility that its ligand may be involved in the proliferation of early hematopoietic cells. late the in vitro growth of leukemic precursor cells. [1] [2] [3] [4] [5] [6] [7] [8] [9] [12] [13] [14] This theoretically may limit their potential use in vivo in the Leukemic clones are known to originate from early progenitors, incapable of further maturation. In a previous report treatment of bone marrow aplasia in preleukemic and leukemic disorders. Despite this concern, myeloid growth factors Vigon et al 42 demonstrated that the transcript for mpl receptors 537 Table 3 Combined effect of MGDF and other growth factors on AML colony growth Cytokines Case No. and FAB subtype
535 ± 20 1 ± 0.5 9 ± 3 4 5 ± 4 KL + MGDF 1172 ± 58 2 ± 1 1 5 ± 4 8 6 ± 6 IL-3 677 ± 35 50 ± 8 2 ± 1 3 2 ± 4 IL-3 + MGDF 650 ± 25 59 ± 8 2 ± 1 1 9 ± 3 GM-CSF 400 ± 15
686 ± 24 35 ± 6 1 0 ± 2 232 ± 15 a 2.5 × 10 4 NALD peripheral blood cells were seeded in triplicate 1 ml agar cultures containing control medium or growth factors at the concentrations illustrated in Table 2 in the absence or in the presence of 50 ng/ml MGDF. Mean ± s.d. of colony counts from triplicate dishes.
was indeed expressed in about 50% of AML cases tested. This finding was subsequently confirmed by several authors. [43] [44] [45] 48 In addition, it has also been demonstrated that c-mpl-expressing acute myeloid leukemia blasts were capable of short term and long term in vitro proliferation when exposed to MGDF alone or in combination with other hematopoietic growth factors. 43, 45, 47 In our hands 9/23 (39%) of the cases were significantly stimulated to proliferate by MGDF. This percentage is quite similar (44%) to that reported by Matsumura et al 43 and higher than that reported by Quentmeier et al. 44 However, with the same criteria adopted by Quentmeier (ie a PI Ͼ 2), our responsive cases become 6/23 (26%) and Matsumura's 11/50 (22%), which are percentages quite similar to those reported by Quentmeier.
The role of MGDF on the growth of leukemic stem cells has been reported, but not yet fully documented; 49 for this reason we examined its ability to support the growth of clonogenic myeloid leukemia stem cells, to determine whether it could act by itself or whether synergistic effects occurred with other hemopoietic growth factors.
In the present paper we show that MGDF not only stimulated the proliferation of primary leukemia blasts, but more significantly, it stimulated the clonal growth of leukemic progenitors, which constitute a small fraction (less than 1% of the leukemic population) capable of a higher proliferative capacity.
The ability of AML cells to grow in the presence of MGDF did not seem to correlate with a distinct morphologic type of myeloid leukemia, the MGDF-responsive cases being of different FAB subtypes. However, the greatest proliferative response, in both short term proliferation and in clonogenic assay, was observed in M6 and M7 cases. This finding was not surprising, since in the normal hematopoiesis MGDF acts as a megakaryocyte growth factor and cooperates in enhancing the growth of early erythropoietic progenitors. 53, 54 How- lineages.
538 Table 4 Effect Our experiments show that MGDF was also capable of stican hardly be explored with conventional proliferation assays. It is possible that, if the receptors could be determined mulating the growth of clonogenic myeloid leukemic cells when the total leukemic population was not responsive in specifically on clonogenic cells, the percentage of c-mplexpressing leukemias would be higher. short-term proliferation assays. Indeed, in five cases leukemic blasts did not seem to proliferate in response to MGDF, while Compared with MGDF, blast cell proliferation and CFU-L growth were stimulated with much higher frequency and to a leukemic colony growth was stimulated by the very factor. This suggests that, in some cases, only leukemic stem cells do higher degree by GM-CSF, IL-3, KL and FL. A strong enhancing effect of MGDF was observed with KL-and with FL-stimuhave receptors for MGDF. It is possible that, as for normal hematopoiesis, mpl is expressed by more primitive progenitors lated leukemic colonies, and to a much lesser extent, with IL-3-and GM-CSF-stimulated colonies. The enhancing effect was and is lost during the progression along lineages other than the erythroid-megakaryocyte lineage. Thus, the growth promoting also reproducible in serum-deprived conditions, thus the influence of other unknown serum factor(s) could be ruled effect of MGDF on more primitive leukemic progenitors appears to involve over 80% of the cases tested. On the other out. The synergic effect of KL and FL was also observed when low concentrations of leukemic blasts were seeded. This hand, the fraction of leukemic stem cells is so small that it
